ATMP
Showing 1 - 25 of 32
Type1diabetes Trial in Uppsala (the ATMP Protrans)
Recruiting
- Type1diabetes
- the ATMP Protrans
-
Uppsala, SwedenUppsala University Hospital
May 16, 2022
Junctional Epidermolysis Bullosa Trial in Salzburg (Transplantation surgery of genetically corrected cultured epidermal
Terminated
- Junctional Epidermolysis Bullosa
- Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)
-
Salzburg, AustriaEB House Austria, Department of Dermatology, Paracelsus Medical
Feb 18, 2022
Recessive Dystrophic Epidermolysis Bullosa Trial in Salzburg (Genetically corrected cultured epidermal autograft (ATMP))
Terminated
- Recessive Dystrophic Epidermolysis Bullosa
- Genetically corrected cultured epidermal autograft (ATMP)
-
Salzburg, AustriaEB House Austria, Department of Dermatology, Paracelsus Medical
Feb 15, 2022
Evaluation of FROM-16 in ATMP Patients & Families
Active, not recruiting
- Family Members
- Cancer
- FROM-16 Questionnaire
- Semi-structured two-part interview
-
Birmingham, United Kingdom
- +4 more
Aug 15, 2022
Urinary Stress Incontinence Trial in Zürich (Muscle Precursor Cells (MPCs), ATMP)
Completed
- Urinary Stress Incontinence
- Muscle Precursor Cells (MPCs), ATMP
-
Zürich, SwitzerlandUniversity Hospital Zurich
Nov 2, 2021
Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome, Idiopathic Nephrotic Syndrome Trial in Milan (Cord-blood
Enrolling by invitation
- Nephrotic Syndrome in Children
- +2 more
- Cord-blood mesenchymal stromal cells
-
Milan, MI, ItalyPediatric Nephrology, Dialysis and Transplant Unit, Fondazione I
Aug 25, 2021
LGMD Trial (GenPHSat injection (Safety), GenPHSat injection (Efficacy), Muscle Biopsy (Safety))
Not yet recruiting
- LGMD
- GenPHSat injection (Safety)
- +2 more
- (no location specified)
Oct 20, 2022
Mitochondrial Myopathies Trial in Maastricht (autologous mesoangioblasts)
Recruiting
- Mitochondrial Myopathies
- autologous mesoangioblasts
-
Maastricht, NetherlandsMaastricht University
Sep 21, 2021
Stroke, Acute, Ischemic Stroke, Acute, Hemorrhagic Stroke Trial (HI-SPEED Protocol)
Not yet recruiting
- Stroke, Acute
- +2 more
- HI-SPEED Protocol
- (no location specified)
Oct 17, 2023
Cartilage Damage Trial in Utrecht (Instant MSC Product accompanying Autologous Chondron Transplantation)
Recruiting
- Cartilage Damage
- Instant MSC Product accompanying Autologous Chondron Transplantation
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Dec 21, 2021
Temporomandibular Joint Disorders, Temporomandibular Disorder, Temporomandibular Joint Osteoarthritis Trial in Kayseri (Stem
Recruiting
- Temporomandibular Joint Disorders
- +4 more
- Stem Cells
-
Kayseri, TurkeyErciyes University
Mar 23, 2022
COVID - 19 Trial in Newcastle (TCB008)
Active, not recruiting
- COVID - 19
-
Newcastle, United KingdomRoyal Victoria Infirmary
Mar 8, 2022
Acute Myeloid Leukemia Trial in Worldwide (Cyclophosphamide-Fludarabine (Cy/Flu), oNKord®)
Recruiting
- Acute Myeloid Leukemia
- Cyclophosphamide-Fludarabine (Cy/Flu)
- oNKord®
-
Ghent, Belgium
- +9 more
Jun 15, 2022
Non Union Fracture Trial in Worldwide (Cultured Mesenchymal Stem Cells, Autologous iliac crest graft)
Active, not recruiting
- Non Union Fracture
- Cultured Mesenchymal Stem Cells
- Autologous iliac crest graft
-
Clermont-Ferrand, France
- +18 more
May 26, 2022
Peripheral Arterial Disease (PAD), Diabetes (DM), Diabetes, Type 1 Trial in Worldwide (REX-001, Placebo)
Terminated
- Peripheral Arterial Disease (PAD)
- +5 more
- REX-001
- Placebo
-
Ostrava, Czechia
- +14 more
May 5, 2021
Acute Traumatic Spinal Cord Injury Trial in Spain (FAB117-HC, Control group)
Recruiting
- Acute Traumatic Spinal Cord Injury
- FAB117-HC
- Control group
-
A Coruña, Spain
- +8 more
Sep 8, 2021
Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))
Active, not recruiting
- Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
- Blinatumomab Expanded T-cells (BET)
-
Bergamo, ItalyASST - Papa Giovanni XXIII
Dec 22, 2021
Cerebrovascular Diseases, Ischemic Stroke, Repository Trial in Los Angeles
Recruiting
- Cerebrovascular Diseases
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Feb 24, 2021
Peripheral Arterial Disease (PAD), Diabetes (DM), Diabetes, Type 1 Trial in Worldwide (REX-001, Placebo)
Recruiting
- Peripheral Arterial Disease (PAD)
- +5 more
- REX-001
- Placebo
-
Innsbruck, Austria
- +27 more
May 4, 2021
Critical Limb Ischemia Trial in Galway City (20 million hMSCs, 40 million hMSCs, 80 million hMSCs)
Completed
- Critical Limb Ischemia
- 20 million hMSCs
- +2 more
-
Galway City, Galway, IrelandGalway University Hospital
Mar 2, 2021
Kidney Transplantation Trial in Germany (MIC, Standard of Care)
Recruiting
- Kidney Transplantation
- MIC
- Standard of Care
-
Frankfurt, Germany
- +4 more
Oct 11, 2022